In cooperation with Vifor Pharma
Inequalities between men and women in both national and international healthcare systems have been augmented by the pandemic. Women comprise the majority of the healthcare workforce globally. As a result, they have been more exposed to the effects of the COVID-19 while their needs have been affected by disruptions in healthcare systems. Women have been impacted by interruptions of reproductive and maternal health services. Shortages in blood supply have put women at higher risk for postpartum hemorrhage and the prevalence of anemia (more prevalent in women) has been indicated as potentially affecting the efficacy of vaccinations.
Chaired by Barbara Angehrn, Chief Business Officer, Vifor Pharma.